KRas G12C inhibitors

H N A IN y R5 / B The present invention provides compounds of the formula: where R, R2, R, R, R, A, B, and Y are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and salts for treating patients for cancer.

Saved in:
Bibliographic Details
Main Authors PENG, Sheng-Bin, GUO, Deqi, SI, Chong, FORTNER, Kevin Charles, BOULET, Serge Louis, HYMAN, David Michael
Format Patent
LanguageEnglish
Published 09.05.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:H N A IN y R5 / B The present invention provides compounds of the formula: where R, R2, R, R, R, A, B, and Y are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and salts for treating patients for cancer.
Bibliography:Application Number: AU20240202573